Literature DB >> 15753301

The protooncogene MYC can break B cell tolerance.

Yosef Refaeli1, Kenneth A Field, Brian C Turner, Andreas Trumpp, J Michael Bishop.   

Abstract

The protooncogene MYC has been implicated in both the proliferation and programmed cell death of lymphoid cells, and in the genesis of lymphoid tumors. Here, we report that overexpression of MYC, as found in many lymphomas, can break immune tolerance. Mice that would otherwise be tolerant to a transgenic autoantigen mounted an immune response to the antigen if MYC was vigorously expressed in the B cell lineage. The responsive B cells converted to an activated phenotype and produced copious amounts of autoantibody that engendered immune complex disease of the kidney. MYC was required to both establish and maintain the breach of tolerance. These effects may be due to the ability of MYC to serve as a surrogate for cytokines. We found that the gene could mimic the effects of cytokines on both B cell proliferation and survival and, indeed, was required for those effects. These findings demonstrate a critical role for MYC in the response of B cells to antigen and expand the potential contributions of MYC to the genesis of lymphomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15753301      PMCID: PMC552974          DOI: 10.1073/pnas.0409832102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Life and death decisions in B1 lymphoma cells.

Authors:  D Donjerković; G B Carey; C M Mueller; S Liu; D W Scott
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

2.  Defining the specific physiological requirements for c-Myc in T cell development.

Authors:  N C Douglas; H Jacobs; A L Bothwell; A C Hayday
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

3.  Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice.

Authors:  C C Goodnow; J Crosbie; S Adelstein; T B Lavoie; S J Smith-Gill; R A Brink; H Pritchard-Briscoe; J S Wotherspoon; R H Loblay; K Raphael
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

4.  c-Myc regulates mammalian body size by controlling cell number but not cell size.

Authors:  A Trumpp; Y Refaeli; T Oskarsson; S Gasser; M Murphy; G R Martin; J M Bishop
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

5.  Blocked B cell differentiation and emigration support the early growth of Myc-induced lymphomas.

Authors:  K A Brandvold; D L Ewert; S C Kent; P Neiman; A Ruddell
Journal:  Oncogene       Date:  2001-05-31       Impact factor: 9.867

6.  Reversible tumorigenesis by MYC in hematopoietic lineages.

Authors:  D W Felsher; J M Bishop
Journal:  Mol Cell       Date:  1999-08       Impact factor: 17.970

7.  Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death.

Authors:  L Van Parijs; Y Refaeli; J D Lord; B H Nelson; A K Abbas; D Baltimore
Journal:  Immunity       Date:  1999-09       Impact factor: 31.745

Review 8.  Translocations involving c-myc and c-myc function.

Authors:  L M Boxer; C V Dang
Journal:  Oncogene       Date:  2001-09-10       Impact factor: 9.867

9.  The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.

Authors:  J M Adams; A W Harris; C A Pinkert; L M Corcoran; W S Alexander; S Cory; R D Palmiter; R L Brinster
Journal:  Nature       Date:  1985 Dec 12-18       Impact factor: 49.962

Review 10.  c-MYC: more than just a matter of life and death.

Authors:  Stella Pelengaris; Mike Khan; Gerard Evan
Journal:  Nat Rev Cancer       Date:  2002-10       Impact factor: 60.716

View more
  16 in total

1.  The transcription factor Bright plays a role in marginal zone B lymphocyte development and autoantibody production.

Authors:  Athenia L Oldham; Cathrine A Miner; Hong-Cheng Wang; Carol F Webb
Journal:  Mol Immunol       Date:  2011-10-02       Impact factor: 4.407

Review 2.  Understanding B-cell tolerance through the use of immunoglobulin transgenic models.

Authors:  Kirthi Raman Kumar; Chandra Mohan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  IL-13 dampens human airway epithelial innate immunity through induction of IL-1 receptor-associated kinase M.

Authors:  Qun Wu; Di Jiang; Sean Smith; Jyoti Thaikoottathil; Richard J Martin; Russell P Bowler; Hong Wei Chu
Journal:  J Allergy Clin Immunol       Date:  2011-12-09       Impact factor: 10.793

4.  B lymphocytes promote lymphogenous metastasis of lymphoma and melanoma.

Authors:  Alanna Ruddell; Maria I Harrell; Momoko Furuya; Sara B Kirschbaum; Brian M Iritani
Journal:  Neoplasia       Date:  2011-08       Impact factor: 5.715

5.  Development of a murine model for blastoid variant mantle-cell lymphoma.

Authors:  Richard J Ford; Long Shen; Yen Chiu Lin-Lee; Lan V Pham; Asha Multani; Hai-Jun Zhou; Archito T Tamayo; ChongJie Zhang; Lesleyann Hawthorn; John K Cowell; Julian L Ambrus
Journal:  Blood       Date:  2007-02-20       Impact factor: 22.113

6.  A role for IRF8 in B cell anergy.

Authors:  Simanta Pathak; Shibin Ma; Vipul Shukla; Runqing Lu
Journal:  J Immunol       Date:  2013-11-11       Impact factor: 5.422

7.  Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target.

Authors:  Ryan M Young; Ian R Hardy; Raedun L Clarke; Nicolai Lundy; Polly Pine; Brian C Turner; Terry A Potter; Yosef Refaeli
Journal:  Blood       Date:  2008-11-03       Impact factor: 22.113

8.  SPLUNC1 regulation in airway epithelial cells: role of Toll-like receptor 2 signaling.

Authors:  Hong Wei Chu; Fabienne Gally; Jyoti Thaikoottathil; Yvonne M Janssen-Heininger; Qun Wu; Gongyi Zhang; Nichole Reisdorph; Stephanie Case; Maisha Minor; Sean Smith; Di Jiang; Nicole Michels; Glenn Simon; Richard J Martin
Journal:  Respir Res       Date:  2010-11-05

9.  TC-PTP is required for the maintenance of MYC-driven B-cell lymphomas.

Authors:  Ryan M Young; Avital Polsky; Yosef Refaeli
Journal:  Blood       Date:  2009-09-15       Impact factor: 22.113

Review 10.  B-cell receptor signaling in the genesis and maintenance of B-cell lymphoma.

Authors:  Ryan M Young; Brian C Turner; Yosef Refaeli
Journal:  Future Oncol       Date:  2008-10       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.